A Phase I Study of Intravenous (IV) Palifosfamide-tris Administered in Combination With IV Etoposide and IV Carboplatin in Patients With Malignancies for Which Etoposide and Carboplatin Are an Appropriate Choice.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2013
At a glance
- Drugs Carboplatin; Etoposide; Palifosfamide
- Indications Cancer
- Focus Adverse reactions
- 17 Jul 2012 Planned end date changed from 1 Jun 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 17 Feb 2012 Planned End Date changed from 1 Jul 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 17 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.